Skip to main content
. 2021 May 20;22(10):5375. doi: 10.3390/ijms22105375

Table 2.

Major events in the liver contributing to nonalcoholic fatty liver disease (NAFLD).

Outcome Causes
Increased influx of the circulating free fatty acids (FFA) Obesity
Overfeeding (also saturated fatty acids)
Rapid weight loss
Total parenteral nutrition (transformation of carbohydrates/proteins to TG)
Decreased mitochondrial β-oxidation of FFA Vitamin B5 (pantothenic acid) deficiency
Excessive alcohol consumption
Drugs: valproic acid or chronic aspirin → coenzyme A deficiency
Decreased activity acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1)
Possible decreased activity of miRNAs
Increased accumulation of ceramides
Decreased secretion/export of very low-density lipoproteins (VLDL) Abetalipoproteinemia, protein malnutrition, or choline deficiency
Defective secretion of postprandial Apo B
Drugs: amiodarone and tetracycline → defective lipidation of Apo B (inhibition of microsomal triglyceride transfer protein (MTP))
Ongoing NAFLD/NASH